✦ LIBER ✦

Vandetanib increases the efficacy of tamoxifen in a preclinical luminal breast cancer model

✍ Scribed by Spanheimer, Philip; Park, Jung M.; Askeland, Ryan W.; Cyr, Anthony R.; Woodfield, George W.; Weigel, Ronald J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Nanoemulsion Formulation of Tamoxifen

✍ Tagne, Jean-Bosco; Kakumanu, Srikanth; Ortiz, Daniela; Shea, Thomas; Nicolosi, R 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 420 KB

Overcoming the loss of efficacy of tamox

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 267 KB

Preclinical studies of the combination o

✍ I. Farmer; Evans; H.A. Lane; A.E. Lykkesfeldt; M. Dowsett; L. Martin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 138 KB

The role of preclinical animal models in

✍ Robert Clarke 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 48 KB

182 Defining efficacy thresholds in prec

✍ M. Prewett; R. Bassi; K. Paz; M. Amatulli; S. Samakoglu; J.R. Tonra 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Tamoxifen stimulation of human breast ca

✍ Reddel, Roger R; Sutherland, Robert L 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 698 KB